Attorney General Mike Hilgers announced that Nebraska’s settlement with eight generic opioid manufacturers for their role in contributing to the opioid epidemic in Nebraska has been finalized.
Attorney General Hilgers joined a bipartisan coalition of state attorneys general in reaching the settlement, which will provide up to $3,082,987 in funding for opioid remediation in Nebraska.
Manufacturers involved in the settlement include Mylan, Hikma, Anneal, Apotex, Indivior, Sun, Alvogen, and Zydus. As a result of the settlements, restrictions are put on their promotion and marketing of opioid products and requires them to implement monitoring and reporting systems for suspicious orders.
The settlements were negotiated by North Carolina, California, Colorado, Illinois, New York, Oregon, Tennessee, Utah, and Virginia.
